Table 1.
Distribution of glomerular diseases based on incidence and patients' sex.
| Diagnosis | Number (%) | Male (%) | Female (%) | P value |
|---|---|---|---|---|
| Primary Glomerulonephritis | ||||
|
| ||||
| MGN | 32 (15.3%) | 20 (22.7%) | 12 (9.9%) | 0.018∗ |
| IgAN | 17 (8.1%) | 9 (10.2%) | 8 (6.6%) | 0.244 |
| FSGS | 12 (5.7%) | 8 (9.1%) | 4 (3.3%) | 0.071 |
| MCD | 10 (4.8%) | 6 (6.8%) | 4 (3.3%) | 0.198 |
| MesPGN | 9 (4.3%) | 5 (5.7%) | 4 (3.3%) | 0.309 |
| MPGN | 9 (4.3%) | 2 (2.3%) | 7 (5.8%) | 0.189 |
| Chronic GN | 9 (4.3%) | 7 (8.0%) | 2 (1.7%) | 0.189 |
| Post infectious GN | 4 (1.9%) | 3 (3.4%) | 1 (0.8%) | 0.202 |
| Alport disease | 1 (0.5%) | 1 (1.1%) | 0 | 0 |
| CGN | 4 (1.9%) | 2 (2.3%) | 2 (1.7%) | 1 |
|
| ||||
| Secondary Glomerulonephritis | ||||
|
| ||||
| Lupus nephritis | 70 (33.5%) | 10 (11.4%) | 60 (49.6%) | < .001∗ |
| Diabetic nephropathy | 23 (11.0%) | 11 (12.5%) | 12 (9.9%) | 0.355 |
| Fibrillary | 5 (2.4%) | 2 (2.3%) | 3 (2.5%) | 0.647 |
| Renal amyloidosis | 4 (1.9%) | 3 (3.4%) | 1 (0.8%) | 0.202 |
|
| ||||
| Total | 209 (100%) | 88 (42.1%) | 121 (57.9%) | |
∗Statistically significant difference. FSGS: focal and segmental glomerulosclerosis; MGN: membranous glomerulonephritis; IgAN: IgA nephropathy; MPGN: membranoproliferative glomerulonephritis; CGN: crescentic glomerulonephritis; MCD: minimal change disease; MesPGN: mesangioproliferative glomerulonephritis; GN: glomerulonephritis.